Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost effectiveness of lead screening.

D M Berwick, A L Komaroff

    The New England Journal of Medicine
    |June 10, 1982
    PubMed
    Summary
    This summary is machine-generated.

    Free erythrocyte protoporphyrin screening is a cost-effective strategy for reducing childhood lead poisoning when prevalence is 7% or higher. This method is superior to blood lead screening and offers net savings, averting childhood disabilities.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Donald M. Berwick on American healthcare and the Institute for Healthcare Improvement. Interview by Chittur A Sivaram and Marva West Tan.

    Journal for healthcare quality : official publication of the National Association for Healthcare Quality·2013
    Same author

    Decline in ICU adverse events, nosocomial infections and cost through a quality improvement initiative focusing on teamwork and culture change.

    Quality & safety in health care·2006
    Same author

    Broadening the view of evidence-based medicine.

    Quality & safety in health care·2005
    Same author

    Lymphocyte subset differences in patients with chronic fatigue syndrome, multiple sclerosis and major depression.

    Clinical and experimental immunology·2005
    Same author

    The improvement horse race: bet on the UK.

    Quality & safety in health care·2004
    Same author

    Clues to chronic fatigue syndrome.

    Health news (Waltham, Mass.)·2004

    Area of Science:

    • Environmental Health
    • Pediatrics
    • Public Health Policy

    Background:

    • Childhood lead poisoning is a significant public health concern, leading to developmental disabilities.
    • Existing lead screening programs aim to mitigate these adverse health outcomes.
    • The cost-effectiveness of different screening strategies requires thorough evaluation.

    Purpose of the Study:

    • To compare the cost-effectiveness of two lead-screening strategies: free erythrocyte protoporphyrin assay (fEP) and blood lead measurement (bLM).
    • To evaluate these strategies against a no-screening approach in a population of three-year-old children.
    • To determine the optimal screening strategy based on lead poisoning prevalence rates.

    Main Methods:

    • A literature review was conducted to gather data on costs, savings, and health benefits.

    Related Experiment Videos

  • A cost-effectiveness analysis was performed comparing fEP screening, bLM screening, and no screening.
  • The analysis considered a population of three-year-old children and varying prevalence rates of lead poisoning.

    • Main Results:

    • Free erythrocyte protoporphyrin screening is more cost-effective than blood lead screening across all prevalence rates.
    • When lead poisoning prevalence is 7% or higher, fEP screening averts morbidity and results in net savings, proving superior to no screening.
    • At prevalences below 7%, the costs of screening and treatment must be weighed against non-economic benefits and societal investments.

    Conclusions:

    • Free erythrocyte protoporphyrin screening is the preferred method for lead screening in children due to its superior cost-effectiveness compared to blood lead measurement.
    • Implementing fEP screening is advisable when lead poisoning prevalence exceeds 7%, as it is both beneficial and economically advantageous.
    • For lower prevalence rates, policy decisions should balance economic costs with the significant non-economic benefits of improved child health and quality of life.